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A B S T R A C T
Although seizures are rarely encountered in Wilson’s disease (WD), seizures related to hypocupremia
have not been reported before.We report a patient presentingwith partial status epilepticus whowas on
strict low-copper diet and chelating therapy for WD. Despite other rare causes of seizures in WD
including penicillamine-induced pyridoxine deﬁciency, cerebral copper deposition and metabolic
encephalopathy, the most probable cause of resistant status epilepticus in this patient was found as
hypocupremia from overzealous treatment. This case exampliﬁes that hypocupremic states should be
kept in mind as a risk factor for resistant seizures.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epileptic seizures have been reported to occur in about 6% of
patients with Wilson’s disease (WD), starting shortly after the
initiation of chelator therapy and responding well to antiepileptic
treatment.1,2 Status epilepticus in WD after starting the treatment
with penicillamine is reported only in one patient in the literature,
where hypocupremia was present though not blamed for
seizures.1 Seizures related to hypocupremia have not previously
been reported in the literature. Here, we present a patient with
Wilson’s disease under strict low-copper diet and chelating
treatment, who was admitted to our hospital due to partial status
epilepticus.
2. Case report
A 21-year-old male patient was brought to our emergency unit
because of recurrent convulsions. The patient was being followed-
up with the diagnosis of Wilson’s disease for ﬁve years in another
center. He was under treatment with zinc (100 mg/day), D-
penicillamine (1200 mg/day), and multivitamins (B1/B6/B12 250/
250/1000 mg/day) in addition to a very strict low-copper diet.
Seven months ago, the patient had experienced difﬁculties in
speaking, swallowing and walking, upon which the dosage of D-
penicillamine was increased and the patient was told to obey his
diet strictly. Few weeks after these changes in his treatment, he
started to have rapid, jerky contractions over his left arm and leg.* Corresponding author at: Fulya mah., Gulseren sok., Aycibin Apt., B Blok, D:22,
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and 2485.6mg/dl in 24-h urine. But nevertheless, the dosage of D-
penicillamine and zinc was increased to treat these contractions
and trihexyphenidyl (15 mg/day) was added to the therapy. After
these arrangements, the contractions over his left arm and leg
showed a prominent deterioration, and he had two consecutive
secondarily generalized seizures, upon which he was admitted to
our emergency department and hospitalized.
At his admission to our hospital, he was apathic with limited
cooperation. His speech was dysarthric and hypophonic, he had
drooling with a ﬁxed open-mouth smile. He had bilateral hand
tremor, truncal ataxia and unsteady gait. He also had generalized
bradykinesia and dystonia being more prominent on his right side,
getting worse with voluntary movements. Other than Wilson’s
disease, his past medical history was unremarkable. There was a
ﬁrst-degree consanguinity between his parents. He had two
healthy brothers (25 and 28 years).
During his stay in hospital, he continuously had partial seizures
as clonic contractions over his left arm and leg, some of which
showed secondary generalization manageable with intravenous
diazepame only. Multiple electroencephalograms (EEG) revealed
diffuse slowing and multifocal left temporo-parieto-occipital and
right centro-frontal epileptiform activity characterised by rhyth-
mic, sharp-contoured theta waves intermixed with fast activity.
Ictal EEG performed at the time of left-sided contractions also
revealed bifrontal epileptiform activity being more prominent on
the right side (Fig. 1). Hewas started on oral levetiracetam therapy,
which was increased up to 1000 mg/day without any beneﬁt. The
therapy was then changed to diphenylhydantoin, which has also
failed in seizure control in spite of high doses (500 mg/day).
Although he was already on multiple vitamin B supplementation,
high doses of intravenous multiple vitamin B replacement therapyvier Ltd. All rights reserved.
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Fig. 1. Ictal EEG demonstrates bifrontal epileptiform activity being more prominent on the right side.
[(Fig._2)TD$FIG]
Fig. 2. The axial T1-weighted cranial MRI reveals the involvement of bilateral
putaminal structures observed as hyperintense signal changes.
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the antiepileptic drugs as levetiracetam and diphenylhydantoin
nor palliative measures as vitamin B replacement therapy were
effective on resistant seizures. Interestingly, the partial status
epilepticus was aborted only on administration of intravenous
diazepame.
The cranial magnetic resonance imaging (MRI) of the patient
performed ﬁve years ago at the time of diagnosis of WD showed
generalized subcortical demyelination as hyperintense signal
changes over bilateral parietotemporal subcortical white matter,
and prominent atrophy in supratentorial deep white matter with
ventricular dilatation in T2 and Flair weighted images. The
repeated cranial MRI during hospitalization revealed that bilateral
putamen, mesencephalon, bilateral middle and superior cerebellar
peduncles were also affected in addition to a more diffuse
subcortical involvement (Fig. 2).
Laboratory investigations excluded any known metabolic or
infectious causes of convulsions, including serum calcium,
magnesium and pyridoxine levels. On the other hand, his serum
copper level was measured as low as 2.2 mg/dl (normal value: 85–
190mg/dl) and copper level in 24-h urine was measured as
165.3 mg/day (normal value: 3–35 mg/day). Upon these ﬁndings,
we stopped D-penicillamine and zinc therapy, and encouraged the
patient to have a high-copper diet. The seizures diminished
distinctly and ceased within few days, and diazepame therapy was
gradually withdrawn in a week. His serum copper level was
increased to 15mg/dl. At this stage, his speech and swallowing also
showed some improvement, he became able to walk without any
assistance. Bradykinesia and right-sided action dystonia were still
present. Hewas dischargedwith zinc therapy only (150 mg/day). A
free diet and weekly measurements of serum copper level were
recommended. After ﬁve months of his admission, serum copper
level was 13.7 mg/dl, copper level in 24 h urine was 135 mg/dl, and
he was still seizure-free.3. Discussion
Epileptic seizures are reported to be rare in Wilson’s disease
occurring in about 6–7% of cases, and to respond well to
antiepileptic treatment.1,2 Status epilepticus in WD was reported
only in one patient in the literature, whichwas reported to develop
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mia was present though it was not accused of seizures.
Mechanisms proposed to be responsible for increased seizure
activity in WD include penicillamine causing pyridoxine deﬁcien-
cy,3 direct effect of copper deposition,4 or metabolic encephalopa-
thy and pathological changes.5 The possible effect of D-
penicillamine on pyridoxine deﬁciency was not accepted as the
cause of resistant seizures in this patient in the presence of a
normal pyridoxine level, and also because seizures did not respond
at all tomultiple vitamin B replacement therapy or the cessation of
D-penicillamine treatment.
Although copper deposition in various parts of cerebral cortex
was proposed to play a role in epileptogenetic processes in some
patients with WD, cerebral changes were not thought to be
responsible from status epilepticus in our patient. Besides, the MRI
ﬁndings of our patient were in consistent with hypocupremia, an
important complication rarely encountered in Wilson’s disease,
resulting from overzealous treatment.6 These central nervous
system changes include bilateral symmetrical demyelinating
lesions in caudate, putamen, substantia nigra, tegmentum,
and thalamus. The authors deﬁning these MRI features have
linked them to hypocupremia and have suggested copper
monitorization.6
Seizures related to hypocupremia have not been reported
before in the literature. Copper is a component of key metalloen-
zymes that have a critical role in the structure and function of the
nervous system. These include cytochrome-c oxidase for electron
transport and oxidative phosphorylation in the mitochondrial
respiratory chain, copper–zinc superoxide dismutase for antioxi-
dant defense, tyrosinase for melanin synthesis, dopamine hydrox-
ylase for catecholamine biosynthesis, and ceruloplasmin for brain
iron homeostasis. Reduction in cytochrome oxidase activity may
be the likely basis for neurological dysfunction associated with the
copper deﬁcient states.7 In Menkes disease, which is an X-linked
genetic disorder of intracellular copper transport, impaired activity
of various copper-dependent enzymes causes the clinical table,
and epileptic seizures are well-known features of the disease. In
one case report, treatment with copper replacement therapy hasbeen shown to be effective in seizure control in a patient with
Menkes disease.8 On this basis, we propose that impaired activity
of copper-dependent enzymes might have led to the resistant
status epilepticus in our patient during hypocupremic state.
In conclusion, we have a patient with a very low serum copper
level due to overzealous treatment of Wilson’s disease, who
presented with resistant partial status epilepticus responsive to
oral diazepame only. These resistant seizures ceased only after the
serum copper level has reached to normal values. This novel case
exampliﬁes that hypocupremic states should be kept in mind as a
risk factor for resistant seizures, especially in patients at risk such
as Wilson’s disease. In addition, serum copper levels should
therefore be monitored to prevent further neurological complica-
tions secondary to copper deﬁcient states.
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